🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessBlue Cross Blue Shield — September 2026

Blue Cross Blue Shield — September 2026

emily_PDX Tue, Jan 21, 2025 at 1:26 AM 22 replies 1,764 viewsPage 1 of 5
This thread is more than 16 months old. Information may be outdated. Consider searching for more recent discussions.
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Jan 21, 2025 at 1:26 AM#1

Putting this up for argument rather than for agreement. I have read it twice and I am still not certain what it supports.

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.

The question I want answered is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. Happy to be told the question itself is wrong.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
26 21julia.endo, JessicaM_2024, TomFromTexas and 23 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jan 21, 2025 at 1:56 AM#2
emily_PDX said:
Denials are usually procedural rather than clinical, and the order that works reflects that.
emily_PDX said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

Last edited: Jan 21, 2025 at 3:56 AM
25 20HPLC_Greg, LibrarianMeg, bri_stats and 22 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Jan 21, 2025 at 2:26 AM#3
emily_PDX said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Pushing back on emily_PDX here. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

24 19Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 21 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Jan 21, 2025 at 2:56 AM#4
Dr.SleepRoch said:
The affordability discussion here usually stops at individual tactics.

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

Last edited: Jan 21, 2025 at 5:56 AM
23 18RickReta_CO, PharmHunterJen, TomTeleRx and 20 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Jan 21, 2025 at 5:39 AM#5
labquiet_amy said:
emily_PDX said: ...my insurance denied cost and coverage coverage because...

Same pattern here, and in the same order.

22 17mike_mealprep, NicoleRaleigh, james_edin and 19 others
Reply Quote Save Share Report
1235

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register